Adagene Inc.

NasdaqGM:ADAG Stock Report

Market Cap: US$100.1m

Adagene Management

Management criteria checks 2/4

Adagene's CEO is Peizhi Luo, appointed in Nov 2011, has a tenure of 6.75 years. directly owns 3.25% of the company’s shares, worth $3.25M. The average tenure of the management team and the board of directors is 6.1 years and 3 years respectively.

Key information

Peizhi Luo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13yrs
CEO ownership3.3%
Management average tenure6.1yrs
Board average tenure3yrs

Recent management updates

Recent updates

Adagene Inc. (NASDAQ:ADAG) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Oct 10
Adagene Inc. (NASDAQ:ADAG) Surges 26% Yet Its Low P/S Is No Reason For Excitement

The Consensus EPS Estimates For Adagene Inc. (NASDAQ:ADAG) Just Fell Dramatically

Oct 05
The Consensus EPS Estimates For Adagene Inc. (NASDAQ:ADAG) Just Fell Dramatically

Adagene ADR GAAP EPS of -$0.87 misses by $0.45, revenue of $3.93M misses by $9.82M

Aug 30

Micro-cap Adagene surges after hours on $10M share buyback

Jun 29

CEO

Peizhi Luo (58 yo)

13yrs

Tenure

Dr. Peter P. Luo, PhD, also known as Peizhi, is the Founder of Adagene Inc. and serves as its Chief Executive Officer since November 2011 and Director since February 2018. He serves as President of R&D at...

Leadership Team

NamePositionTenureCompensationOwnership
Peter P. Luo
Co- Founder13yrsno data3.25%
$ 3.3m
Man Kin Tam
CFO & Director5.2yrsno datano data
Jc Xu
Chief Scientific Officer4.3yrsno datano data
Ami Knoefler
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Ling Zhou
Head of Human Resources5.1yrsno datano data
Qinghai Zhao
Chief Manufacturing Officer4.1yrsno datano data
Yan Li
Senior Vice President of Bioinformatics & Information Technology13yrsno datano data
Xiaohong She
Senior VP & Head of Clinical Operations13yrsno data0.094%
$ 94.4k
Guizhong Liu
Senior Vice President of Early Drug Discovery9.1yrsno datano data
Alexander Goergen
VP & Head of Business Development7.1yrsno datano data
Jiping Zha
Executive Vice President of Clinical Development3.1yrsno datano data
Songmao Zheng
VP and Head of Clinical & Quantitative Pharmacologyno datano datano data

6.1yrs

Average Tenure

55yo

Average Age

Experienced Management: ADAG's management team is seasoned and experienced (6.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter P. Luo
Co- Founder6.8yrsno data3.25%
$ 3.3m
Man Kin Tam
CFO & Director3.8yrsno datano data
Li Zhu
Independent Director1.3yrsno datano data
Steven Alan Fischkoff
Member of Scientific & Strategic Advisory Board3.3yrsno datano data
Robert Jay Spiegel
Member Scientific and Strategic Advisory Board3.3yrsno datano data
Mervyn J. Turner
Independent Director1.6yrsno datano data
Cuong Viet Do
Independent Director2yrsno datano data
David R. Gandara
Member Scientific & Strategic Advisory Board2.8yrsno datano data
Yumeng Wang
Director1.6yrsno datano data
Aurelien Marabelle
Member of Scientific & Strategic Advisory Board1.7yrsno datano data
Yiu Leung Cheung
Independent Director3.8yrsno datano data
Stanley Frankel
Member Scientific & Strategic Advisory Board3.3yrsno datano data

3.0yrs

Average Tenure

65yo

Average Age

Experienced Board: ADAG's board of directors are considered experienced (3 years average tenure).